At the beginning of last summer, a trial conducted on 5,000 adolescents and young women in the most HIV ... against infection, although he notes that a dosing regimen of two 'shots' a year also ...

Twice-yearly shots ... for HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect against infection. The results in women were published ...

Two shots a year ... a study among young women and adolescent girls in Africa. The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrati ...

“A twice-yearly PrEP choice could overcome challenges with respect to adherence and result in substantial protection against HIV infection for women worldwide,” the study authors wrot ...

There were no infections in the young women and girls that got the shots ... HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and ... effective at protecting people from ...

A new study has shown that twice-yearly shots are 100% effective in preventing new HIV infections among women. Involving 5,000 participants in South Africa and Uganda, the shots, already approved ...

(AP Photo/Nardus Engelbrecht) CAPE TOWN, South Africa (AP) — Twice-yearly shots ... for HIV. The company said it is waiting for the results of testing in men before seeking permission to use it to ...